- Home » News and EventsPage 23
NEWS & EVENTS
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Catalent Completes Acquisition of Gene Therapy Leader Paragon Bioservices, Inc. for $1.2 Billion
May 20, 2019
Catalent, Inc. (NYSE: CTLT) today announced that it has completed the $1.2 billion acquisition of Paragon Bioservices, Inc., a leading viral vector development and manufacturing partner for gene therapies.
Catalent Achieves Global ISO Accreditation
May 9, 2019
Catalent today announced that the British Standards Institute has awarded Catalent a global accreditation against the international management standards for environment and Occupational Safety.
Catalent Receives RoSPA Silver Award
May 7, 2019
SOMERSET, N.J. – May 7, 2019 — Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that…
Catalent Collaborates with MGB Biopharma
Apr 25, 2019
SOMERSET, N.J. – April 25, 2019 — Catalent, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced t…
Technologies to Improve Patient Adherence and to be Discussed at CPhI NA
Apr 24, 2019
SOMERSET, N.J. – April 24, 2019 — Catalent (booth 1206), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, toda…
Catalent Invests $14 Million at its Eberbach, Germany Softgel Facility
Apr 23, 2019
Catalent Invests $14 Million at its Eberbach, Germany Softgel Facility. SOMERSET, N.J. – April 23, 2019 — Catalent, the leading global diversified provider of advanced delivery technologies and develo…
Patient-Centric Workshop to be Presented GCSG US
Apr 18, 2019
Catalent will also Discuss Direct-to-Patient Clinical Supplies, the Impact of Brexit on VAT Handling, and Japan’s Cultural and Regulatory Environment. SOMERSET, N.J. – April 18, 2019 — Catalent, a glo…
Catalent to acquire gene therapy leader Paragon Bioservices
Apr 15, 2019
Catalent to acquire gene therapy leader Paragon Bioservices. (NYSE: CTLT), the leading global diversified provider of advanced delivery technologies and development solutions for drugs, biologics and …
Catalent Celebrates Opening of Second Shanghai Facility
Apr 11, 2019
SOMERSET, N.J. – April 11, 2019 — Catalent Pharma Solutions, a global leader in clinical supply services, today announced the completion of its new, 30,000-square-foot clinical supply facility in Shan…
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.